Longitudinal analysis of pneumococcal antibodies during community-acquired pneumonia reveals a much higher involvement of Streptococcus pneumoniae than estimated by conventional methods alone

Clinical and Vaccine Immunology

Volumn 18, Issue 5, 2011, Pages 796-801

  Van Mens, Suzan P ^a   Meijvis, Sabine C A ^a   Endeman, Henrik ^a,c   Van Velzen Blad, Heleen ^a   Biesma, Douwe H ^a,b   Grutters, Jan C ^a   Vlaminckx, Bart J M ^a   Rijkers, Ger T ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CORTICOSTEROID; PLACEBO;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BACTERIUM IDENTIFICATION; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; COXIELLA BURNETII; FEMALE; HAEMOPHILUS INFLUENZAE; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; INTERMETHOD COMPARISON; LEGIONELLA; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIAE; PREDICTIVE VALUE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; TEACHING HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NETHERLANDS; PNEUMONIA, BACTERIAL; PREVALENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 79955716440     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00007-11     Document Type: Article

References (31)

1. Abdeldaim, G., et al. 2010. Usefulness of real-time PCR for lytA, ply, and Spn9802 on plasma samples for the diagnosis of pneumococcal pneumonia. Clin. Microbiol. Infect. 16:1135-1141.
2. Alanee, S. R., et al. 2007. Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin. Infect. Dis. 45:46-51.
3. Reference deleted.
4. Berntsson, E., K. A. Broholm, and B. Kaijser. 1978. Serological diagnosis of pneumococcal disease with enzyme-linked immunosorbent assay (ELISA). Scand. J. Infect. Dis. 10:177-181.
5. Bogaert, D., R. De Groot, and P. W. Hermans. 2004. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis. 4:144-154.
6. Delsing, C. E., and B. J. Kullberg. 2008. Q fever in the Netherlands: a concise overview and implications of the largest ongoing outbreak. Neth. J. Med. 66:365-367.
7. de Roux, A., et al. 2006. Mixed community-acquired pneumonia in hospitalised patients. Eur. Respir. J. 27:795-800.
8. Endeman, H., et al. 2008. Clinical features predicting failure of pathogen identification in patients with community acquired pneumonia. Scand. J. Infect. Dis. 40:715-720.
9. File, T. M. 2003. Community-acquired pneumonia. Lancet 362:1991-2001.
10. Fine, M. J., et al. 1997. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 336:243-250.
11. Go, E. S., and Z. K. Ballas. 1996. Anti-pneumococcal antibody response in normal subjects: a meta-analysis. J. Allergy Clin. Immunol. 98:205-215.
12. Harboe, Z. B., et al. 2009. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med. 6:e1000081.
13. Heron, M., et al. 2009. Deaths: final data for 2006. Natl. Vital Stat. Rep. 57:1-134.
14. Jansen, A. G., et al. 2009. Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. Clin. Infect. Dis. 49:e23-e29.
15. Jefferson, T., E. Ferroni, F. Curtale, P. Giorgi Rossi, and P. Borgia. 2006. Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old. Lancet Infect. Dis. 6:405-410.
16. Johansson, N., M. Kalin, A. Tiveljung-Lindell, C. G. Giske, and J. Hedlund. 2010. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin. Infect. Dis. 50:202-209.
17. Kalin, M., and A. A. Lindberg. 1985. Antibody response against the type specific capsular polysaccharide in pneumococcal pneumonia measured by enzyme linked immunosorbent assay. Scand. J. Infect. Dis. 17:25-32.
18. Lucero, M. G., et al. 2009. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. Cochrane Database Syst. Rev. (4):CD004977.
19. Mandell, L. A. 2004. Epidemiology and etiology of community-acquired pneumonia. Infect. Dis. Clin. North Am. 18:761-776, vii.
20. Moberley, S. A., J. Holden, D. P. Tatham, and R. M. Andrews. 2008. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst. Rev. (1):CD000422.
21. Musher, D. M., et al. 1993. Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination. Clin. Infect. Dis. 17:66-73.
22. Musher, D. M., et al. 1997. Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides. J. Invest. Med. 45:57-68.
23. Pickering, J. W., et al. 2002. A multiplexed fluorescent microsphere immunoassay for antibodies to pneumococcal capsular polysaccharides. Am. J. Clin. Pathol. 117:589-596.
24. Ridda, I., et al. 2009. Immunological responses to pneumococcal vaccine in frail older people. Vaccine 27:1628-1636.
25. Ruiz-Gonzalez, A., M. Falguera, A. Nogues, and M. Rubio-Caballero. 1999. Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia. Am. J. Med. 106:385-390.
26. Siber, G. R., et al. 2007. Estimating the protective concentration of antipneumococcal capsular polysaccharide antibodies. Vaccine 25:3816-3826. (Pubitemid 46589754)
27. Simell, B., M. Lahdenkari, A. Reunanen, H. Kayhty, and M. Vakevainen. 2008. Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins. Clin. Vaccine Immunol. 15:1391-1397.
28. Soininen, A., et al. 2009. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants. Vaccine 27:2680-2688.
29. Werno, A. M., and D. R. Murdoch. 2008. Medical microbiology: laboratory diagnosis of invasive pneumococcal disease. Clin. Infect. Dis. 46:926-932.
30. 29a.World Health Organization. International clinical trials registry platform ID NCT00471640. http://apps.who.int/trialsearch/Trial.aspx?TrialID= NCT00471640.
31. Zysk, G., et al. 2003. Immune response to capsular polysaccharide and surface proteins of Streptococcus pneumoniae in patients with invasive pneumococcal disease. J. Infect. Dis. 187:330-333.